GLP-1
Tirzepatide
Own facility · GLP-1 Peptides
Tirzepatide is a dual GIP and GLP-1 receptor agonist for type 2 diabetes and weight management, given as a once-weekly subcutaneous injection. BOOKPHARM supplies tirzepatide as an active ingredient and supports finished-dosage development.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| FDFGLP-1 | API + FDF CMO/Supply | Approval in Iran and Laos |
| APIGLP-1 | API supply | NDC+US DMF |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.